Puma Biotechnology Inc (PBYI) earnings · P/E 19, rev $228.4M
These earnings events as JSON? API free 100/dayPuma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
This PBYI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PBYI revenue for 2025-12-31 was $228.4M. Net income was $31.1M. Revenue was down 0.9% from 2024-12-31 to 2025-12-31. PBYI currently screens at market cap $165.3M and trailing P/E 19.3.
When the next PBYI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 0.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PBYI research stays on the stock page; the tape stays on the quote page.
PBYI earnings FAQ
What are PBYI's latest revenue and net income?
Latest cached Puma Biotechnology Inc (PBYI) revenue for Dec 31, 2025 was $228.4M. Net income was $31.1M. Statements: https://lician.com/financials/pbyi
What is PBYI's latest diluted EPS?
Latest cached Puma Biotechnology Inc (PBYI) diluted EPS for Dec 31, 2025 was $0.61.
What period does the latest PBYI earnings print cover?
The latest cached Puma Biotechnology Inc (PBYI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PBYI revenue change from the prior cached period?
Cached Puma Biotechnology Inc (PBYI) revenue was down 0.9% from $230.5M (Dec 31, 2024) to $228.4M (Dec 31, 2025). Statements: https://lician.com/financials/pbyi
What is PBYI's P/E ratio?
Puma Biotechnology Inc (PBYI) trailing P/E is 19.3 on the latest cached fundamentals snapshot.
Where are PBYI earnings listed?
Cached earnings facts for Puma Biotechnology Inc (PBYI) are listed at https://lician.com/earnings/pbyi. Statements: https://lician.com/financials/pbyi
Not investment advice.